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INTRODUCTION
Otitis media with effusion (OME) is characterized by the accumu-
lation of fluid within the middle-ear cavity without acute symp-
toms such as fever or otalgia. Its etiology includes adenoid veg-
etation, allergic rhinitis, chronic sinusitis, Eustachian tube dys-
function due to cleft palate, bacterial infection and immune sys-
tem defects (1, 2).
In patients with Eustachian tube dysfunction producing a venti-
lation defect, the air in the middle ear cavity is inhaled via a mucos-
al layer, generating a negative pressure in the middle ear cavity.
Patients with persistent negative pressure show medial retraction
of the tympanic membrane, as well as increased capillary perme-
ability, due to swelling and vascular dilatation in the middle ear
mucosa. This leads to exudate accumulation in the middle-ear
cavity. The exudate becomes condensed over time, acting as a
medium for bacterial cell growth and infection. 
The fluid secreted from the middle ear mucosa in patients with
otitis media has greater concentrations of glycoproteins and IgA
than does the serum. In addition, mucus secreted by middle-ear
goblet cells and glandular tissue has local defense functions (3).
The activity of antibodies involved in the defense mechanism
of the middle-ear cavity is regulated by transcription factors that
regulate the synthesis of antibodies. Among these transcription
factors are B-cell leukemia lymphoma-6 (Bcl-6), B-lymphocyte
inducer of maturation program 1 (Blimp-1), Paired box gene 5
(Pax-5) and X-box binding protein 1 (XBP-1). Bcl-6 and Pax-5
suppress, while Blimp-1 and XBP-1 enhance, immunoglobulin
secretion. There are correlations among these transcription fac-
tors, in that Bcl-6 inhibits the activity of Blimp-1, Blimp-1 inhibits
the activity of Pax-5, and Pax-5 inhibits the activity of XBP-1.
Therefore, as the concentrations of Bcl-6 and Pax-5 are increased,
those of Blimp-1 and XBP-1 are decreased (4).
In patients with OME, the type and amount of antibody in the
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Original Articleeffusion has a crucial defensive role in local immunity. Although
many studies have assessed bacterial flora and antibody charac-
teristics of effusion fluid, no studies to date have assessed the
expression of transcription factors associated with the synthesis
of antibodies. We therefore determined the concentrations of
immunoglobulin and transcription factor mRNAs in the middle-
ear fluid of patients with chronic OME and evaluated the differ-
ences between OME and OME-prone children. 
MATERIALS AND METHODS
Patients
The subject cohort consisted of 61 pediatric patients who visited
the pediatric ear, nose and throat clinic of Kyung Hee University
between March 2006 and February 2008 and underwent tym-
panostomy tube surgery for chronic OME. Subjects included 29
children with recurrent OME (>4 episodes in 12 months or >3
in 6 months; OME-prone group) and 32 with fewer episodes of
OME who did not recover spontaneously (OME group). We
divided the OME patients into those positive and negative for
bacteria in effusion fluid by the bacterial culture method. The
OME-prone group consisted of 17 boys and 12 girls, aged 5.3±
2.4 yr (mean±standard deviation [SD] range, 4 to 11 yr). The
OME group consisted of 20 boys and 12 girls, aged 4.9±2.3 yr
(range, 1 to 9 yr). 
OME was diagnosed by the presence of an amber-colored
tympanic membrane on otoscopic examination or by the pres-
ence of B- or C-type tympanograms as shown by impedance
audiometry. Surgery was performed on chronic OME patients
who did not show improvement after 2 weeks of antibiotic treat-
ment and in patients who, after a 2-3 month follow up, showed
progressive retraction of the eardrum or hearing loss progression,
as shown by an increase in pure tone threshold. Children with
head or neck deformities, systemic diseases, or those suspected
of having congenital or acquired immune deficiencies were ex-
cluded from this study. 
Prior to surgery, the external auditory canal was washed with
potadine solution and effusion fluid was collected aseptically into
an Eppendorf tube, being careful to avoid bleeding. Each effu-
sion fluid sample was diluted 10 fold and centrifuged, and each
supernatant and pellet were stored separately at -70℃. Prior to
surgery, the purpose of sample collection was explained to the
parents or guardians of each child, and written informed consent
was obtained. 
Bacterial culture
Each effusion fluid sample was collected using sterilized cotton
swabs, added to Stuart transport medium, and used to inoculate
blood agar medium and thioglycollate liquid medium. The cul-
tures were incubated for 24 hr at 35℃, and resultant bacteria
were identified by gram staining and biochemical tests. 
Real-Time PCR
Gene expression was quantified using real-time polymerase chain
reaction (PCR) (Roche Diagnostics, Mannheim, Germany). To
establish relative measures for Bcl-6, Blimp-1, Pax-5 and XBP-
1, we first used primers for β -2 microglobulin based on sequences
in GenBank. Each primer pair spanned an intron to remove the
effects of any genomic DNA contaminants (Table 1). The num-
ber of threshold cycles for each target gene was obtained, and the
crossing point of each with β -2 microglobulin was entered into
the formula 2-(target gene-β 2 microglobulin) for relative quantification.
Enzyme-linked immunosorbent assay (ELISA) 
All middle-ear effusion samples were stored at -80℃, and the con-
centrations of IgG, IgA, and IgM in each sample were measured
by ELISA. Briefly, 50 μ L of 1:100 goat anti-human IgG, anti-
human IgA, or anti-human IgM in coating buffer (1.59 g Na2CO3,
2.93 g NaHCO3, 5% NaN3, pH 9.6) were placed in each well of
a 96-well plate and incubated overnight at 4℃. The wells were
washed six times, blocking antibody was added and 50 μ L of
sample was added to each well followed by incubation at room
temperature for 3 hr. The wells were washed six times, purified
goat anti-human IgG, IgA, or IgM conjugated to horseradish per-
oxidase in PBS/Tween/BSA solution was added, and the plates
were incubated at room temperature. The plates were washed
six times, substrate solution (2,2′ -AZINO-Bis) was added, and
the optical absorbance was measured at 450 nm (Bethyl, Mont-
gomery, TX, USA).
Statistical analysis
The data were analyzed by student’s t-test using SPSS ver. 13.0,
with a P-value less than 0.05 considered statistically significant. 
RESULTS
The mean relative levels of Blimp-1 (22.7±1.8 vs. 24.3±1.8,
P<0.05) and XBP-1 (22.9±1.9 vs. 24.2±1.7, P<0.05) mRNA
were significantly lower in the OME-prone than in the OME
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Name Sequences
Annealing Product 
temperature size
Table 1. Primer sequences for real-time polymerase chain reaction
Bcl-6 5′ -TTCATCGTGCTCAACAGCCTCAAC-3′ 60°C 393 bp
5′ -ATCTGAGTACTCAGACTGGGTCTC-3′ 55°C 210 bp
Blimp-1 5′ -CACCTGAGAGTGCACAGTGG-3′
5′ -CACAAACTGGGTGAACTTGGC-3′
Pax-5 5′ -CTGATCTCCCAGGCAAACAT-3′ 55°C 198 bp
5′ -TTGCTCATCAAGGTGTCAGG-3′
XBP-1 5′ -TTAGAAGAAGAGAACCAAAAAC-3′ 55°C 241 bp
5′ -ACGTAGTCTGAGTGCTG-3′
β 2-microg- 5′ -CTTCTACAATGAGCTGCGTG-3′ 60°C 305 bp
lobulin 5′ -TCATGAGGTAGTCAGTCAGG-3′group. In contrast, the mean relative levels of Bcl-6 (25.9±2.5
vs. 25.6±2.1) and Pax-5 (23.7±2.3 vs. 23.3±1.9) mRNA were
slightly higher in the OME-prone than in the OME group, but
these differences were not statistically significant (P>0.05) (Fig.
1, Table 2). 
Bacteria were detected in 15/61 (24.5%) effusion fluid sam-
ples. Among the bacteria detected by bacterial culture were S.
pneumonia (4 patients), H. influenzae (3 patients), M. catarrhalis
(3 patients), MRSA (3 patients), coagulase negative Staphyloco-
ccus (2 patients), and P. aeruginosa (1 patient). 
The mean relative levels of Blimp-1 (23.2±2.1 vs. 24.0±1.9)
and XBP-1 (23.2±1.9 vs. 23.9±1.7) mRNA were lower in the
culture (+) than in the culture (-) group. The mean relative lev-
els of Bcl-6 (25.8±2.5 vs. 25.7±2.3) and Pax-5 (23.8±2.2 vs.
23.1±2.1) mRNA were slightly higher in the culture (+) than
in the culture (-) group, but none of these differences was statis-
tically significant (P>0.05) (Table 3).
When we measured the overall concentration of immunoglob-
ulins in the ear fluid of patients with chronic OME, we found
that the concentration of IgA was significantly lower in the OME-
prone than in the OME group (330±248 ng/mL vs. 668±425
ng/mL, P<0.05) (Table 4). In contrast, although the concentra-
tions of IgG (1,775±1,469 ng/mL vs. 2,983±2,371 ng/mL) and
IgM (677±680 ng/mL vs. 1,568±762 ng/mL) were lower in the
OME-prone than in the OME group, these differences were not
statistically significant. 
DISCUSSION
Clinically, otitis media has been found to recur frequently in some
pediatric patients. The otitis-prone condition, defined as >3 epi-
sodes in 6 months or >4 in one year, has been observed in ap-
proximately 5% of pediatric patients with OME (5). Chronic
symptoms of OME are due mainly to secondary changes and
the resulting dysfunction of the Eustachian tubes (1, 2). These
secondary changes include the impaired production of antibod-
ies, cilia dysfunction, mucosal swelling and hyperplasia, mucoid
changes in secretions, fibrosis, edema and overproduction of
mucus due to increased numbers of goblet cells and glandular
tissue. Recent studies in patients with OME have assessed bac-
teria, cells, cytokines and antibodies in the middle-ear fluid (3,
6-8). Chronic OME frequently occurs after recurrent acute otitis
media (AOM) or upper respiratory infection. Therefore bacteri-
al infection is suggested as the major cause of chronic OME (9).
Sloyer et al. (10) reported that a negative bacterial culture is
correlated with the level of specific antibody, indicative of the
eradication of bacteria by specific antibody. We attempted to
evaluate the level of transcription factor for target antibodies,
not the levels of specific antibodies, since we did not perform
bacterial DNA fingerprinting. Therefore we could not determine
whether the chronic OME is a recurrent infection or another in-
fection (11).
Although extraction of middle-ear mucosa would provide sam-
ples for accurate, detailed evaluation of the status of the middle-
ear cavity, middle-ear mucosa cannot be extracted for ethical
reasons. Thus, although our methods were indirect, evaluating
middle-ear fluid from patients, it provides accurate concentra-
tions of transcription factors and immunoglobulins in the mid-
dle-ear fluid of patients with OME. Studies performed in patients
with acute otitis media have shown that IgA concentrations are
higher in middle-ear fluid than in blood of patients with OME,
whereas the concentrations of IgM and IgG are lower in middle-
ear fluid than in serum (8, 10). 
The concentrations of IgG2 and IgA have been reported to
be lower in the serum and middle ear fluid of patients with recur-
rent OME than in those with OME (12). Moreover, the serum
and middle ear fluid concentrations of IgG specific for Moraxella
catarrhalis were found to be lower in OME-prone than in OME
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Bcl-6 Blimp-1 Pax-5 XBP-1
Table 2. Relative transcription factor level in middle-ear cavity fluid
in the otitis media with effusion (OME) and OME-prone groups  
OME-prone 25.9±2.5 22.7±1.8* 23.7±2.3 22.9±1.9*
OME 25.6±2.1 24.3±1.8 23.3±1.9 24.2±1.7
*P<0.05, Crossing point: 2-(
target gene-β 2 microglobulin).
Bcl-6 Blimp-1 Pax-5 XBP-1
Table 3. Relative level of transcription factor in the middle ear cavi-
ty fluid of the bacterial culture (+) and culture (-) groups
Culture (+) 25.8±2.5 23.2±2.1 23.8±2.2 23.2±1.9 
Culture (-) 25.7±2.3 24.0±1.9 23.1±2.1 23.9±1.7 
Crossing point: 2-(
target gene-β 2 microglobulin).
Total otitis media  
OME-prone OME  group
Table 4. Concentrations of immunoglobulins in middle-ear effusion
fluid of patients in the otitis media with effusion (OME) and OME-
prone groups  
IgG (ng/dL) 2,375±1,565 1,775±1,469 2,983±2,371 
IgA (ng/dL) 485±352 330±248* 668±425* 
IgM (ng/dL) 1,053±642 677±680 1,568±762 
*P<0.05.
Fig. 1. Expression of Bcl-6, Pax-5, XBP-1, and Blimp-1 mRNAs in mid-
dle-ear cavity fluid of patients in the otitis media with effusion (OME)
and OME-prone groups. Polymerase chain reaction products were
separated on a 2% agarose gel and stained with ethidium bromide.
N: normal peripheral blood, P: middle-ear cavity fluid.
NP N PN P N P NP
Bcl-6 Marker
500 bp
200 bp
PAX-5 XBP-1 Blimp-1 β -actinpatients (13). In those reports, however, the causes of OM, in-
fected organs, and types of antibody were diverse. In our study
we evaluated the correlation between IgA concentration and
transcription factors for antibodies in chronic OME patients who
did not respond to drug treatment for 2 weeks and with a 3 month
follow-up. 
Unlike IgG or IgM, IgA is primarily synthesized by plasma cells
present in the respiratory and intestinal mucosae and in glandu-
lar tissue. Thus, although some IgA is present in the blood, most
is present in the epithelium or the spaces between epithelia as
secretory immunoglobulin A (sIgA). In patients with acute otitis
media, bacterial stimulation of local immunity in the middle-ear
cavity leads to the increased synthesis of sIgA. However, in pa-
tients with decreased concentrations of IgA due to defects in its
production, the impairment of local immunity in the middle-ear
cavity causes the recurrence and chronic changes observed in
patients with OME. In support of this finding, we also observed
that the IgA concentration was significantly lower in the OME-
prone than in the OME group.
Inflammatory cells observed in the middle-ear fluid of patients
with OME, whether of serous or mucous origin, consist of 50%
neutrophils, 30% macrophages and 20% lymphocytes (5, 6).
Neutrophils and macrophages, which are components of the in-
nate immune system, directly engulf the pathogens. The innate
immune system shows a shorter time to response and a wider
range of antibacterial activity than the acquired immune system,
which involves antibodies and immune system cells. B-lympho-
cytes, which are responsible for humoral immunity in the acqu-
ired immune system, respond to specific antigens and produce
antibodies. These antibodies neutralize the antigens in vivo and
then remove them, according to pathways specific for each anti-
body isotype (14). In the last stage of antigenic stimulation, B-
lymphocytes differentiate into plasma cells in the germinal cen-
ter. Plasma cells produce high-affinity antibodies and often sur-
vive in the bone marrow for several months. The transformation
of B-2 cells into plasma cells involves four transcription factors
involved in the production of immunoglobulins, Bcl-6, Blimp-1,
Pax-5 and XBP-1 (4, 15-19). Bcl-6 and Pax-5 suppress the dif-
ferentiation of B-cells into plasma cells in the germinal center,
as well as suppressing the production of antibodies by plasma
cells (15, 17). In contrast, Blimp-1 and XBP-1 are transcription
factors that terminate the cell cycle and promote B-cell differ-
entiation. 
In addition to inhibiting B-cell differentiation, Bcl-6 inhibits
the expression of genes involved in B-cell activity and those that
encode the cyclin-dependent kinase (cdk) inhibitors, p27 and
p21. Thus, Bcl-6 suppresses prompt cell differentiation. The major
role of Bcl-6 is to suppress the expression of Blimp-1 and the dif-
ferentiation of B-cells into plasma cells. 
Blimp-1 induces the expression of the cdk inhibitor p18, which
is needed for differentiation into plasma cells, the proapoptotic
genes GADD45 and GADD153, and J chain, XBP-1 and HSP-
70 mRNAs, all of which are involved in the secretion of immu-
noglobulins (16). We found that Blimp-1 mRNA expression and
the concentration of IgA were significantly lower in the OME-
prone than in the OME group. Blimp-1 may suppress antibody
production, causing decreased immunity to bacterial and viral
antigens, thus providing clues to its involvement in the progres-
sion of chronic OME.
Like Bcl-6, Pax-5 is needed to suppress B-cell differentiation
into plasma cells in the germinal center and to suppress antibody
production. Pax-5 can activate or inhibit the activity of transcrip-
tion factors. However, we found no intergroup differences in the
concentrations of Pax-5 and Bcl-6. This may be due to persistent,
repetitive antigen stimulation, which may lead to the expression
of transcription factors involved in the suppression of immuno-
globulin secretion. Reduced expression of Pax-5 may induce
expression of XBP-1 and immunoglobulin heavy chain, suggest-
ing that, in B-lymphocytes, the overproduction of Pax-5 suppress-
es the differentiation of plasma cells and decreases antibody pro-
duction (17).
In the absence of XBP-1, T-cells and B-cells develop normal-
ly and the formation of germinal centers and the production of
cytokines are normal. However, lymphocyte production of im-
munoglobulins is severely impaired, suggesting that XBP-1 is
an essential factor for differentiation into plasma cells. We found
that the expression of XBP-1 mRNA was significantly lower in
the OME-prone than in the OME group, suggesting that decreased
production of antibodies is related to the recurrence of OME.
The levels of Blimp-1 and XBP-1 were lower in the culture
(+) group than in the culture (-) group but these differences were
not statistically significant. Increased levels of specific antibod-
ies for S. pneumoniae and H. influenza in middle ear fluid have
been reported to correlate with negative bacterial cultures in acute
OM patients, indicating that the bacteria had been eliminated by
a specific antibody (10). Although not statistically significant,
the lower levels of Blimp-1 and XBP-1 in the culture (+) group
strongly suggest that the decreased level of antibody specific tran-
scription factor was associated with decreased antibody produc-
tion, thus reducing the rates of elimination of bacteria and spe-
cific antibody. In general, PCR is used to identify bacteria, show-
ing a greater than 2-fold sensitivity compared with convention-
al culture methods (20). PCR, however, can also detect the pres-
ence of a previous infection or inactive bacteria. The addition
of PCR may result in the more accurate evaluation of antibody
transcription factor. 
This study is the first to assess this previously established par-
adigm in the fluid of patients with recurrent OME. We found that
the expression of Blimp-1 and XBP-1 mRNA was significantly
lower in the OME-prone than in the OME group. Moreover, des-
pite a lack of statistical significance, the expression levels of Bcl-
6 and Pax-5 mRNA were higher in the OME-prone than in the
OME group. These results are in agreement with the previous
paradigm for transcription factors (4, 15-19). They suggest that
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Our findings also suggest that expression of Bcl-6 and Pax-5 sup-
presses antibody production, whereas expression of Blimp-1 and
XBP-1 promotes it. Impaired production of antibodies against
antigens invading the middle-ear cavity may be related to the
recurrence and chronic changes observed in patients with recur-
rent OME.
We have observed expression of mRNAs encoding transcrip-
tion factors associated with B-cell antibody production in the
middle-ear fluid of pediatric patients with chronic OME. Decrea-
sed levels expression of Blimp-1 and XBP-1 mRNA are associ-
ated with impaired production of IgA in OME prone patients. 
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